.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Dow
Merck
Mallinckrodt
Daiichi Sankyo
Chubb
Argus Health
Harvard Business School
Chinese Patent Office
Healthtrust
Moodys

Generated: September 22, 2017

DrugPatentWatch Database Preview

LANOXIN Drug Profile

« Back to Dashboard

What is the patent landscape for Lanoxin, and when can generic versions of Lanoxin launch?

Lanoxin is a drug marketed by Concordia Pharms Inc and Covis Pharma Bv and is included in two NDAs.

The generic ingredient in LANOXIN is digoxin. There are ten drug master file entries for this compound. Forty suppliers are listed for this compound. Additional details are available on the digoxin profile page.

Summary for Tradename: LANOXIN

Patents:0
Applicants:2
NDAs:2
Suppliers / Packagers: see list12
Bulk Api Vendors: see list69
Clinical Trials: see list7
Patent Applications: see list9,909
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:LANOXIN at DailyMed

Pharmacology for Tradename: LANOXIN

Ingredient-typeCardiac Glycosides
Drug ClassCardiac Glycoside
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Concordia Pharms Inc
LANOXIN
digoxin
TABLET;ORAL020405-001Sep 30, 1997RXYesNo► Subscribe► Subscribe► Subscribe
Covis Pharma Bv
LANOXIN
digoxin
INJECTABLE;INJECTION009330-002Approved Prior to Jan 1, 1982APRXYesYes► Subscribe► Subscribe► Subscribe
Concordia Pharms Inc
LANOXIN
digoxin
TABLET;ORAL020405-004Sep 30, 1997ABRXYesYes► Subscribe► Subscribe► Subscribe
Covis Pharma Bv
LANOXIN PEDIATRIC
digoxin
INJECTABLE;INJECTION009330-004Approved Prior to Jan 1, 1982RXYesYes► Subscribe► Subscribe► Subscribe
Concordia Pharms Inc
LANOXIN
digoxin
TABLET;ORAL020405-002Sep 30, 1997ABRXYesNo► Subscribe► Subscribe► Subscribe
Concordia Pharms Inc
LANOXIN
digoxin
TABLET;ORAL020405-003Sep 30, 1997RXYesNo► Subscribe► Subscribe► Subscribe
Concordia Pharms Inc
LANOXIN
digoxin
TABLET;ORAL020405-006Sep 30, 1997DISCNNoNo► Subscribe► Subscribe► Subscribe
Concordia Pharms Inc
LANOXIN
digoxin
TABLET;ORAL020405-005Sep 30, 1997DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Cerilliant
UBS
Covington
Baxter
McKinsey
Harvard Business School
Moodys
Teva
Healthtrust
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot